|
Post by pmikeks on Feb 14, 2015 13:01:56 GMT -5
Maybe the show 20-20 where 20 to him, 20 to Affezza and 20 to his other contributions.
|
|
|
Post by Chris-C on Feb 14, 2015 13:52:16 GMT -5
Al Mann needs to be on a 60 minute interview talking about his life and his inventions including the insulin pump, cochlear ear implant and Afrezza kc: Clearly more people need to know about Al Mann and why he started Mannkind. There are so few entrepreneurs who are motivated by leaving a legacy for humankind these days that it's no wonder there is skepticism. That said, I'm torn between the rampant enthusiasm for getting the word out and letting the product sell itself over time. Mr. Mann is not beating his chest and spending his time drumming up business because he knows that the product will be successful. That he moved on to his next "legacy" project recently may be the least appreciated event that has occurred during the history of this company, simply because to me his actions signaled that he has confidence that the momentum and "moving parts" are now in place to realize his dream. The money will follow (which at this point in his life is of secondary concern to him anyway). If there is too much promotion and marketing by investors, the skepticism will only increase; because most people can see it for what it is in those cases—motivated by self interest and greed. Mr. Mann is content to let the people with proven success on the front lines sell the product. I respect his judgment— because nothing provides more credibility than proven success that validates his good judgment—in Mr. Mann's case, over and over again. GLTA Chris-C
|
|
|
Post by robsacher on Feb 14, 2015 15:57:08 GMT -5
I hope Al Mann will be around and on 60 Minutes next year. Today, we need to let Sanofi do their job with doctors in the doctor's offices. However, we can certainly provide Sam Finkin's twitter page link wherever it makes sense but please refrain from debate in diabetes forums. Don't go there. It is not helpful. I learned the hard way. twitter.com/afrezzauser
|
|
|
Post by robsacher on Feb 14, 2015 16:17:05 GMT -5
Do you know a good friend or family member who is diabetic and may possibly be interested in Afrezza? Someone who poorly controls their current insulin regiment and someone who is not good at maintaining a low carb diet may be a perfect candidate for starting insulin therapy with Afrezza. This might be a much better idea than trying to educate or persuade naysayers on the internet. Talk to that one person who trusts you and tell them about Sam Finkin and give them Sam's twitter page: twitter.com/afrezzauser.
|
|
|
Post by mrmookie123 on Feb 15, 2015 16:11:52 GMT -5
So, Trish got to you Mr. Sacher
|
|
|
Post by lynn on Feb 15, 2015 20:58:19 GMT -5
Rob Sacher , My mom has a RN coworker in Michigan who's a type 1. I guess she has issues with her pump on a regular basis . My mom told her about Afrezza & she watched Afrezzausers YouTube video . She already had a f/u appointment with her Endo scheduled ( in next cpl weeks) and is eager to try it She sounds like an ideal Afrezza patient , my fingers are crossed that her Endo will have been visited by a Sanofi rep . According to my mom her Doc is the kind who stays up to date re: treatment options for Diabetics so we shall see I'll be sure to let you all know as soon as I find out more Lynn
|
|
|
Post by itrade on Feb 16, 2015 14:03:51 GMT -5
|
|
|
Post by robsacher on Feb 16, 2015 14:21:35 GMT -5
lynn,
You made my day. Your story is exactly what I had in mind when I suggested that people talk with their friends who trust them rather than try and debate the naysayers in diabetic forums.
RS
|
|
|
Post by robsacher on Feb 16, 2015 14:26:28 GMT -5
Hi mrmookie,
Nah, this is not about Trish but she certainly turned the issue into a debate about my credibility and that was not helpful for folks who may be interested in Afrezza. I just want to be helpful and that means finding the best way in order to make that happen.
|
|
|
Post by kc on Feb 16, 2015 15:30:00 GMT -5
|
|
|
Post by mannmade on Feb 16, 2015 15:34:40 GMT -5
allafrica.com/stories/201502161719.htmlNigeria: 12 Diabetes, Hypertension Clinics Coming As Sanofi, Govt Partner By Sola Ogundipe / in Health 12:05 am / Comments TWELVE new dedicated diabetes and hypertension clinics are in the pipeline for 2015, in selected states of the Federation as part of efforts to support patients with the disorders to enable them better manage and control the burden of the two ailments. The first of such clinics which are being set up by the health authorities in collaboration with Sanofi Nigeria, was recently inaugurated, at the Lagos State University Teaching Hospital, LASUTH. Speaking in Lagos during the introduction of its brand of human insulin "Insuman", General Manager, Sanofi Nigeria-Ghana, Abderrahmane Chakibi, noted that the company was reinforcing its commitment to diabetes through new treatment. "In 2015, across Nigeria, we will support the creation of 12 clinics for diabetes and hypertension in partnership with health authorities. These clinics will be established in dedicated healthcare centers to increase screening, disease awareness and patient education. They will also provide better management and monitoring of people with diabetes though dedicated nursing and physician support," Chakbi stated. With the introduction of the new insulin product from its range of diabetes treatments, Sanofi is now the only company to provide a full range of both oral and injectable treatments for patients with diabetes in Nigeria. Chakbi said the 12 new clinics would deliver innovative treatments and a full portfolio adapted to the needs of patients locally. "In 2016, we aim to deploy 24 more clinics. The availability of the new range of human insulin, the injection pen and the support of clinics for the better management of the disease is in direct response to the healthcare needs of patients with diabetes in Nigeria." In Nigeria, around five million people are afflicted with diabetes and the figure is expected to double within the next 20 years, with 63 percent undiagnosed and many that are diagnosed, not correctly controlled. Worse still, 76 percent of deaths due to diabetes are in people under the age of 60 on the African continent. Patients are exposed to many complications including vascular complications, blindness and limb amputation, which can be prevented by treatment with Insulin and effective, close management of patients. The diabetic product range allows for individualised treatment (basal, rapid and premix) available in both Vials and Cartridges that use a unique innovative technology that ensures a more accurate dosing. I The insulin brand which has been licensed in 90 countries is manufactured to the highest international standards in Germany, and has accummulated more than five million patient-years.
|
|
|
Post by mannmade on Feb 16, 2015 15:35:53 GMT -5
We have previously posted articles from Israel, Russia, England and Africa as well...
|
|
|
Post by xoxoxoxo on Feb 16, 2015 16:42:49 GMT -5
|
|
|
Post by EveningOfTheDay on Feb 16, 2015 16:44:00 GMT -5
I found a new old article, Inhaled Insulin is Dead, Long Live Inhaled Insulin, published in 2008. Obviously new for me since I had never set my eyes on it, which kind of surprised me because I tend to think that I have read everything that is out there ... which, actually, only proves how self delusional I can be. Anyway, I am sure many here will have read it already, it even might have been posted before, but decided to post it just in case. The last paragraph really resonates as one of the reasons I believe Mannkind is at the verge of a medication delivery revolution for which it will continue to have an edge for decades to come. closeconcerns.com/press/article_inhaled-insulin_0308.pdf
|
|
|
Post by mnkdfan on Feb 17, 2015 15:27:36 GMT -5
|
|